Trials / Completed
CompletedNCT04272541
Effectiveness of a Psychoeducation Program in Patients With Severe Mental Disorder
Effectiveness of a Psychoeducation Program on Metabolic Syndrome, Cardiovascular Risk, Independency and Psychopatology in Patients With Severe Mental Illness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Universidad de Granada · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Patients with Severe Mental Disorder (SMD) show a life expectancy of 13 to 30 years lower than the general population. Among the factors that determine this expectancy are cardiovascular risk and the metabolic syndrome. The objective of the present study will be to evaluate the effectiveness of a rehabilitative intervention comprinsing a psychopharmacology and psychoeducation program on cardiovascular risk, metabolic syndrome, independency for activities of daily living and psychopathological symptoms.
Detailed description
It will be selected sixty patients diagnosed with SMD from a community Mental Health Unit from Spain. It will be implemented a intervention program consisted of psychopharmacology + psychoeducation on healthy living habits during three months. The patients will be evaluated at the beginning, at three months and at six months follow-up for weight, waist circumference, waist-hip ratio, body mass index, cardiovascular risk, independency and psychopathology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Psychoeducation program | Intervention program consisted of psychopharmacology + psychoeducation. This will be executed during 3 months, distribuited in several sessions. |
| DRUG | Psychopharmacology intervention | Intervention program consisted of psychopharmacology. This will be executed during 3 months. |
Timeline
- Start date
- 2020-02-20
- Primary completion
- 2020-11-20
- Completion
- 2020-11-20
- First posted
- 2020-02-17
- Last updated
- 2021-07-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04272541. Inclusion in this directory is not an endorsement.